References

Mitochondrial quality control mechanisms as molecular targets in diabetic heart

10.1016/j.metabol.2022.155313 · 2022 · External reference

The effect of unhealthy lifestyle on the pathogenesis of sick sinus syndrome: a life-guiding review

2024 · External reference

Targeting mitochondria by lipid-selenium conjugate drug results in malate/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression

10.7150/ijbs.102424 · 2024 · External reference

Potential candidates of natural antioxidants from herbs for treating lung disorders: focus on redox balance and natural products

10.1002/ptr.70008 · 2025 · External reference

CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis

10.1016/j.phrs.2022.106086 · 2022 · External reference

Dihydromyricetin attenuates diabetic cardiomyopathy by inhibiting oxidative stress, inflammation and necroptosis via sirtuin 3 activation

10.3390/antiox12010200 · 2023 · External reference

ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition

10.1038/nchembio.2239 · 2017 · External reference

GLP-1-based therapies for diabetes, obesity and beyond

10.1038/s41573-025-01183-8 · 2025 · External reference

The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease

10.1038/s41569-022-00735-4 · 2023 · External reference

Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes

10.1056/nejmoa2107519 · 2021 · External reference

Liraglutide attenuates doxorubicin-induced cardiomyocyte ferroptosis via DHHC7-mediated STAT3 palmitoylation

10.1016/j.lfs.2025.123912 · 2025 · External reference

Glycemia reduction in type 2 diabetes—microvascular and cardiovascular outcomes

10.1056/nejmoa2200436 · 2022 · External reference

Heart failure in diabetes

10.1016/j.metabol.2021.154910 · 2021 · External reference

Tirzepatide once weekly for the treatment of obesity

10.1056/nejmoa2206038 · 2022 · External reference

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

10.1038/s41392-023-01400-z · 2023 · External reference

Exploring the molecular mechanisms of tirzepatide in alleviating metabolic dysfunction-associated fatty liver in mice through integration of metabolomics, lipidomics, and proteomics

10.1186/s12944-024-02416-2 · 2025 · External reference

Long-term administration of Western diet induced metabolic syndrome in mice and causes cardiac microvascular dysfunction, cardiomyocyte mitochondrial damage, and cardiac remodeling involving caveolae and caveolin-1 expression

10.1186/s13062-023-00363-z · 2023 · External reference

Hyperglycemia-induced DNA damage response activates DNA-PK complex to promote endothelial ferroptosis in type 2 diabetic cardiomyopathy

10.7150/thno.109514 · 2025 · External reference

Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis

10.1038/s41467-024-48970-2 · 2024 · External reference

Insulin resistance and coronary microvascular dysfunction: a complex interplay

10.1186/s12933-025-03068-x · 2026 · External reference

Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta-analysis

10.1161/jaha.121.023207 · 2022 · External reference

The role of PINK1–Parkin in mitochondrial quality control

10.1038/s41556-024-01513-9 · 2024 · External reference

Unresolved reference

2011 · External reference

Tirzepatide for heart failure with preserved ejection fraction and obesity

10.1056/nejmoa2410027 · 2025 · External reference

Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality

10.3389/fphar.2024.1422686 · 2024 · External reference

Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction

10.1007/s10456-024-09938-4 · 2024 · External reference

2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis

10.1038/s41392-024-01816-1 · 2024 · External reference

Ginsenoside Rb1 attenuates coronary microvascular inflammatory injury via NDUFS4-SIRT5-DUSP1-mediated mitochondrial quality control in a murine ischemia–reperfusion model

10.1016/j.jgr.2025.04.006 · 2025 · External reference

Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury

10.1016/j.phymed.2025.156982 · 2025 · External reference

Long-chain acyl-CoA synthetase-1 mediates the palmitic acid-induced inflammatory response in human aortic endothelial cells

10.1152/ajpendo.00117.2020 · 2020 · External reference

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice

10.1172/jci146353 · 2021 · External reference

Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue

10.1016/j.molmet.2022.101550 · 2022 · External reference

Endoplasmic reticulum–mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis

10.1038/s41556-025-01668-z · 2025 · External reference

Increasing fatty acid oxidation prevents high-fat diet–induced cardiomyopathy through regulating Parkin-mediated mitophagy

10.1161/circulationaha.119.043319 · 2020 · External reference

Ferrostatin-1 alleviates tissue and cell damage in diabetic retinopathy by improving the antioxidant capacity of the Xc--GPX4 system

10.1038/s41420-022-01141-y · 2022 · External reference

A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5-DUSP1 axis for mitochondrial repair

10.1186/s12951-025-03667-6 · 2025 · External reference

Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease

10.1016/j.cell.2017.09.021 · 2017 · External reference

Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide

10.1186/s12933-024-02319-7 · 2024 · External reference

Semaglutide administration protects cardiomyocytes in db/db mice via energetic improvement and mitochondrial quality control

10.1038/s41401-024-01448-9 · 2025 · External reference

Mitophagy for cardioprotection

10.1007/s00395-023-01009-x · 2023 · External reference

Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action

10.1038/s41569-023-00849-3 · 2023 · External reference

DNA-PKcs-driven YAP1 phosphorylation and nuclear translocation: a key regulator of ferroptosis in hyperglycemia-induced cardiac dysfunction in type 1 diabetes

2025 · External reference

Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-dependent mitophagy

10.7150/ijbs.95853 · 2024 · External reference

Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance

10.1186/s12951-025-03420-z · 2025 · External reference

Gentiopicroside modulates glucose homeostasis in high-fat-diet and streptozotocin-induced type 2 diabetic mice

2023 · External reference

Insufficient S-adenosylhomocysteine hydrolase compromises the beneficial effect of diabetic BMSCs on diabetic cardiomyopathy

10.1186/s13287-022-03099-1 · 2022 · External reference

Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases

10.1186/s12933-025-02614-x · 2025 · External reference

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

10.1172/jci.insight.140532 · 2020 · External reference

Microtubules and cardiovascular diseases: insights into pathology and therapeutic strategies

10.1016/j.biocel.2024.106650 · 2024 · External reference

Metabolic coordination structures contribute to diabetic myocardial dysfunction

10.1161/circresaha.124.326044 · 2025 · External reference

Organelle dynamics of endothelial mitochondria in diabetic angiopathy

10.1016/j.ejphar.2021.173865 · 2021 · External reference

Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart

10.1002/jcp.31149 · 2024 · External reference

Potential of natural drug modulation of endoplasmic reticulum stress in the treatment of myocardial injury

10.1016/j.jpha.2024.101034 · 2024 · External reference

AP39 inhibits ferroptosis by inhibiting mitochondrial autophagy through the PINK1/parkin pathway to improve myocardial fibrosis with myocardial infarction

10.1016/j.biopha.2023.115195 · 2023 · External reference

Regulation of ferroptotic cancer cell death by GPX4

10.1016/j.cell.2013.12.010 · 2014 · External reference

Astragaloside VI attenuates mechanical stress-induced cardiac remodeling through piezo1-VDAC1 dependent endoplasmic reticulum unfolded protein response

10.1016/j.phymed.2025.157288 · 2025 · External reference

Curcumin attenuates ferroptosis-induced myocardial injury in diabetic cardiomyopathy through the Nrf2 pathway

2022 · External reference

Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway

10.4239/wjd.v16.i12.112423 · 2025 · External reference